'World's largest portfolio': Why this ASX cannabis share is up 36% in August

Investors have rewarded recent news.

| More on:
A little boy surrounded by green grass and trees looks up at the sky, waiting for rain or sunshine.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Incannex shares have spiked in August following a key update
  • The company has executed a transaction outlined earlier in the year
  • Incannex is still down 56% on the charts this YTD

ASX cannabis share Incannex Healthcare Ltd (ASX: IHL) has caught a bid last week, reversing off 52-week lows to now trade 36% higher on the month.

Just after the open on Monday, Incannex is priced at 27.5 cents – not far off its yearly low of 19 cents on 1 August.

What's boosting this ASX cannabis share?

Last week Incannex advised it had finalised the acquisition of APIRx Pharmaceuticals after the pair signed binding terms back in March this year.

CEO and managing director of Incannex, Joel Latham, said the company was "excited" to get the ball rolling on the deal.

"After extensive due diligence and corporate strategy assessments of the APIRx assets," he said, "we are excited and readied to commence development activities over our newly acquired portfolio of drug candidates."

As a result of the transaction, 22 additional clinical and pre-clinical projects have been transferred onto Incannex's books.

The company says this represents an aggregate addressable market of US$400 billion per annum.

As a result, Incannex says it now has the "world's largest portfolio of patented medicinal cannabinoid drug formulations and psychedelic treatment protocols".

This involves an intellectual property portfolio covering 19 granted patents and 23 pending patents, the company says.

Incannex share price snapshot

Investors rallied behind the ASX cannabis share last week. They sent it surging back into the green, bouncing off its 52-week low in the process.

The Incannex share price has now jumped more than 36% in the first week of August. This brings total losses to the year back to 56%.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Woman going for a scan reassured by doctor
Healthcare Shares

How AI could boost this ASX 300 healthcare stock

The Firetrail investment management team see AI providing a 'material tailwind' for this stock.

Read more »

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
Healthcare Shares

Why is the ResMed share price diving 5% today?

Weight loss wonder drugs are weighing heavily on this stock.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Why is the Telix share price jumping 15% to a record high?

This healthcare stock is scaling new heights on Thursday. But why?

Read more »

Stressed thoughtful old female general practitioner doctor physician looking in distance, considering difficult medical problem solution or illness treatment, working on computer in clinic office.
Healthcare Shares

How much do you need to invest in CSL shares for $8,000 in annual dividends?

CSL's dividends are exponentially more valuable for long-term investors.

Read more »

smiling health care workers in a medical setting
Healthcare Shares

'Critical unmet need': Why everyone is talking about this ASX 200 healthcare stock

This healthcare stock has been given a boost from the US FDA today.

Read more »

Senior woman with caregiver in the garden
Healthcare Shares

Why this ASX 200 stock is a retiree's dream

I think this is a very healthy and resilient stock.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

3 ASX 200 healthcare stocks that could deliver big returns for investors

Analysts see a lot of value in these stocks at current levels.

Read more »

A team of people giving the thumbs up sign representing APA and Wesfarmers doing a deal to study green hydrogen transport using an APA gas pipeline
Healthcare Shares

Why are so many top fundies overweight on CSL shares?

This is a healthy opportunity, according to a number of fund managers.

Read more »